April 4, 2025

Google-backed AI drug discovery startup raises $600 million

Isomorphic Labs

Investment raised

USD 600m

Valuation

Region

🏆 Deal of the Week · CW 14/2025

Isomorphic Labs raised USD 600 million in a Venture – Series Unknown round, with the valuation remaining undisclosed; the transaction closed in March 2025. The round was backed by Alphabet, Google Ventures, and Thrive Capital. This deal was recognised as Venionaire DealMatrix's Deal of the Week for KW 14/2025.

Isomorphic Labs — key deal facts

Company Isomorphic Labs
Founded 2021
Headquarters London, United Kingdom
Amount raised USD 600m
Valuation Valuation Remains Undisclosed
Round Venture – Series Unknown
Investors Alphabet, Google Ventures, Thrive Capital
Sectors Artificial Intelligence (AI)

Who invested in Isomorphic Labs?

The investor syndicate comprises Alphabet, Google Ventures, and Thrive Capital. The participation of both Alphabet and its venture arm Google Ventures underscores the deep structural relationship between Isomorphic Labs and its parent organisation, while Thrive Capital's involvement introduces a prominent independent growth-stage investor to the cap table. The combination signals strong conviction across both strategic and financial investors in AI-driven drug discovery.

What does Isomorphic Labs do?

Isomorphic Labs is an artificial intelligence company headquartered in London, United Kingdom, focused on applying machine learning to accelerate drug discovery. Founded on 24 February 2021 by Demis Hassabis, the company was spun out of DeepMind as an Alphabet subsidiary. Its most prominent product is AlphaFold3, co-developed with Google DeepMind, which predicts the three-dimensional structures of biological molecules. The company's core mission is to build predictive and generative AI models that design novel drug candidates and reduce the volume of experimental work required in early-stage pharmaceutical research.

Isomorphic Labs valuation & multiples

No existing multiples analysis was provided for this deal, and the valuation remains undisclosed, precluding EV/Sales or EV/EBITDA calculations at this time. As comparable benchmarks become available, this page will be updated accordingly. For sector-level valuation context, visit the Venionaire DealMatrix Artificial Intelligence multiples pages.

Frequently asked questions

How much did Isomorphic Labs raise in its Venture – Series Unknown?

Isomorphic Labs raised USD 600 million in a Venture – Series Unknown round that closed in March 2025.

What is Isomorphic Labs's valuation?

The valuation of Isomorphic Labs in connection with this round has not been publicly disclosed.

Who invested in Isomorphic Labs?

The round was backed by Alphabet, Google Ventures, and Thrive Capital.

When was Isomorphic Labs founded and where is it based?

Isomorphic Labs was founded on 24 February 2021 and is headquartered in London, United Kingdom.

Source: original announcement — read the full report.

VENIONAIRE DEALMATRIX MULTIPLES

Stop guessing your multiple.

DealMatrix gives you market-realistic EV/Sales and EV/EBITDA multiples for private companies, filtered by sector, stage and region, built on 20 years of data and IPEV-2025-compliant.